Consortium for HIV/aids vaccine development

Ended Cooperative Agreement Awarded Last action

Award ID
UM1AI144462
Recipient
Awarding agency
Obligated
$459,447,135

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Funding
  • $425,958,389.54 Federal
  • $33,488,745.00 Non-federal
Place of performance
La Jolla, CA 92037, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $21,000,000 $0
Amendment $21,000,000 $0
Amendment -$149,788 $0
Amendment -$149,788 $0
Amendment -$149,788 $0
Amendment -$149,788 $0
Amendment -$149,788 $0
Amendment $21,000,000 $0
Amendment $21,000,000 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $30,204,757 $0
Amendment $30,204,757 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment Identification of neutralizing epitopes on sars-COV-2 spike for design of vaccines and small-molecule antivirals - coronaviruses (covs) are enveloped,… -$0 $0
Amendment -$0 $0
Amendment -$0 $0
Amendment -$0 $0
Amendment Identification of neutralizing epitopes on sars-COV-2 spike for design of vaccines and small-molecule antivirals - coronaviruses (covs) are enveloped,… -$0 $0
Amendment -$0 $0
Amendment $18,808,739 $0
Amendment Identification of neutralizing epitopes on sars-COV-2 spike for design of vaccines and small-molecule antivirals - coronaviruses (covs) are enveloped,… $18,808,739 $0
Amendment $18,808,739 $0
Amendment $18,808,739 $0
Amendment Identification of neutralizing epitopes on sars-COV-2 spike for design of vaccines and small-molecule antivirals - coronaviruses (covs) are enveloped,… $21,000,000 $0
Amendment $21,000,000 $0
Amendment $21,000,000 $0
Amendment $21,000,000 $0
Amendment Identification of neutralizing epitopes on sars-COV-2 spike for design of vaccines and small-molecule antivirals - coronaviruses (covs) are enveloped,… $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment Identification of neutralizing epitopes on sars-COV-2 spike for design of vaccines and small-molecule antivirals - coronaviruses (covs) are enveloped,… $0 $0
Amendment $4,581,937 $4,581,937
Amendment $4,581,937 $0
Amendment $4,500,000 $0
Amendment $4,500,000 $4,500,000
Amendment $2,771,189 $0
Amendment $2,771,189 $2,771,189
Amendment $635,619 $635,619
Amendment $635,619 $0
Amendment $21,000,000 $0
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Subawards

Subrecipient Amount Awarded
International Aids Vaccine Initiative Inc. Amendment is to fund the next period of performance of the UM1 AI144462-07 award as described in the attached budget. Year 7 period of performance is from… $83,808
International Aids Vaccine Initiative Inc. Award revised to reflect year 7 funding $749,658
The General Hospital Corporation this award is to provide additional funding for mouse studies $793,750
The General Hospital Corporation This award is to provide the reamaining 50% of the proposed study $538,766
La Jolla Institute For Immunology Amendment to provide the 2nd installment of remaining 50%funding for New NHP studies $2,771,000
International Aids Vaccine Initiative Inc. The amendment is to fund the next period of performance of the UM1 AI144462-07 award as described in the attached budget. Year 7 period of performance is from… $1,295,227
Emory University award revised for year 7 funding $627,560
Emory University award has been revised to reflect Year 07 funding $2,245,490
Emory University award has been revised to reflect Year 7 funding (Y6 carry forward). $374,092
The Administrators Of Tulane Educational Fund Tulane National Primate Research Center will provide highly integrated clinical management and laboratory investigations using Rhesus macaque model to study the… $2,561,458
International Aids Vaccine Initiative Inc. The amendment is to fund the next period of performance of the UM1 AI144462-07 award as described in the attached budget. $45,789
La Jolla Institute For Immunology This amendment is to provide 50% funding for New NHP studies- N332-GT. ALD+mRNA. A cure study. PCT130 and Human naive B cell sorting $2,771,000
The Administrators Of Tulane Educational Fund The amendment is to fund the next period of performance $884,679
The General Hospital Corporation Award revised to add 50% of the proposed study in SOW the remaining 50% of the funds will be provided once spending and work completed progresses. $538,766
La Jolla Institute For Immunology Award revised to add funding for the 2 CHAVD projects $1,152,000
The General Hospital Corporation Award revised to reflect Year 7 Funding. $121,100
The General Hospital Corporation Award revised to reflect Year 7 funding. $61,408
Emory University Award has been revised to reflect Year 7 funding $44,984
The General Hospital Corporation Award has been revised to reflect Year 7 funding. $967,904
The Rockefeller University This award has been revised to reflect Year 7 Funding. $593,077
Fred Hutchinson Cancer Research Center Award revised to reflect Year 7 funding $609,917
International Aids Vaccine Initiative Inc. $310,178
La Jolla Institute For Immunology Award has been revised to refelect year 7 funding $1,166,218
Emory University Amendment to fund additional costs for Dr. Scherer's study under the award $40,814
Show all 24

Quick answers

Who received award UM1AI144462?

UM1AI144462 was awarded to Scripps Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2019.

How much is award UM1AI144462 worth?

$459,447,135 has been obligated on UM1AI144462: $425,958,390 in federal funding and $33,488,745 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login